The Ontario Brain Institute recently announced $600,000 in funding to the 2023 NERVE cohort, a group of six entrepreneurs funded through Canada's single largest award for early-stage neurotechnology companies. The Neurotech Entrepreneurship to Validate Emerging Innovations (NERVE) program provides $100,000 to awarded Canadian-based entrepreneurs, in addition to 12 months of training and mentorship opportunities.
Congratulations to the NERVE cohort and special shout-out to OBIO® member, Foqus Technologies, that is also a part of our current CAAP® cohort.